Inspiration Healthcare (LSE:IHC) reported a robust performance for FY26, with revenue increasing 24% to £47.5 million, supported by strong demand for its SLE neonatal ventilation products. Sales of SLE products climbed 56% during the year, helping to improve gross margins and drive adjusted EBITDA to £2.8 million.
The group also strengthened its balance sheet through tighter working capital management, generating £7.5 million in operating cash flow and reducing net debt by 39% to £5.1 million. Operational improvements boosted manufacturing efficiency and contributed to a one-third reduction in inventory levels.
Strong Trading Supported by Key Contracts
During the year, Inspiration Healthcare completed a significant one-off export contract worth £9.5 million and delivered 10% underlying growth across the SLE business. The company also secured a multi-year purchasing agreement for its Airon division with a major U.S. healthcare provider, further expanding its presence in a key market.
Management highlighted the benefits of ongoing operational improvements, which have increased production capacity while supporting better inventory control and cash generation.
Strategic Shift Towards Core Neonatal Technologies
Following the year-end, the company agreed to transfer its infusion business to Micrel, a move designed to increase focus on its higher-priority neonatal technology operations. The disposal is expected to streamline the business and allow management to concentrate resources on areas with stronger long-term growth potential.
Despite the planned exit from lower-margin infusion distribution activities, the board expressed confidence in achieving market expectations for FY27 and remains optimistic about prospects heading into FY28.
Focused Platform for Future Growth
The company believes its combination of neonatal ventilation expertise, international distribution capabilities and growing U.S. presence provides a solid foundation for future expansion. Management expects continued investment in core technologies and operational efficiency to support further growth and profitability improvements.
Market Considerations
The company’s outlook continues to be influenced by concerns around financial performance, including historical losses, margin pressure, leverage and cash flow challenges. However, positive technical indicators, including a strong share price trend and favourable momentum signals, provide some support. Valuation remains constrained by negative earnings metrics and the absence of a positive price-to-earnings ratio.
More About Inspiration Healthcare
Inspiration Healthcare Group is a UK-based medical technology company focused on products used in neonatal intensive care. Its portfolio includes neonatal ventilators, respiratory support systems and single-use medical consumables designed to support premature and critically ill newborns.
The company markets both proprietary and distributed products directly to healthcare providers in the UK and Ireland, while also serving international markets through a distributor network spanning more than 75 countries. Its operations include SLE, a specialist in neonatal ventilation; Airon, a U.S.-based pneumatic ventilation business; and its UK and Ireland medical technology distribution division.
Leave a Reply